title: Cellular and molecular effects of vitamin D on carcinogenesis.
abstract: Epidemiologic data suggest that the incidence and severity of many types of cancer inversely correlates with indices of vitamin D status. The vitamin D receptor (VDR) is highly expressed in epithelial cells at risk for carcinogenesis including those resident in skin, breast, prostate and colon, providing a direct molecular link by which vitamin D status impacts on carcinogenesis. Consistent with this concept, activation of VDR by its ligand 1,25-dihydroxyvitamin D (1,25D) triggers comprehensive genomic changes in epithelial cells that contribute to maintenance of the differentiated phenotype, resistance to cellular stresses and protection of the genome. Many epithelial cells also express the vitamin D metabolizing enzyme CYP27B1 which enables autocrine generation of 1,25D from the circulating vitamin D metabolite 25-hydroxyvitamin D (25D), critically linking overall vitamin D status with cellular anti-tumor actions. Furthermore, pre-clinical studies in animal models has demonstrated that dietary supplementation with vitamin D or chronic treatment with VDR agonists decreases tumor development in skin, colon, prostate and breast. Conversely, deletion of the VDR gene in mice alters the balance between proliferation and apoptosis, increases oxidative DNA damage, and enhances susceptibility to carcinogenesis in these tissues. Because VDR expression is retained in many human tumors, vitamin D status may be an important modulator of cancer progression in persons living with cancer. Collectively, these observations have reinforced the need to further define the molecular actions of the VDR and the human requirement for vitamin D in relation to cancer development and progression.
authors.affiliation: Cancer Research Center, University at Albany, Rensselaer, NY 12144, USA. jwelsh@albany.edu
authors.forename: JoEllen
authors.initials: J
authors.lastname: Welsh
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology*; D018167:Receptors, Calcitriol / Q000378:metabolism; D014807:Vitamin D / Q000378:metabolism*
chemical_list: D018167:Receptors, Calcitriol; D014807:Vitamin D
references.citation: J Cell Biochem. 2007 Aug 15;101(6):1505-19
references.pmid: 17286279
references.citation: J Invest Dermatol. 2009 Jun;129(6):1367-78
references.pmid: 19052561
references.citation: Br J Pharmacol. 1998 Nov;125(5):953-62
references.pmid: 9846632
references.citation: J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):403-7
references.pmid: 20214986
references.citation: Nat Med. 2004 Sep;10(9):917-9
references.pmid: 15322538
references.citation: PLoS One. 2011 Jan 26;6(1):e16479
references.pmid: 21298063
references.citation: Carcinogenesis. 2009 Jan;30(1):88-92
references.pmid: 19017685
references.citation: BMC Cancer. 2010 Sep 11;10:483
references.pmid: 20831823
references.citation: Rev Endocr Metab Disord. 2012 Mar;13(1):31-8
references.pmid: 21861107
references.citation: Nature. 2009 Mar 26;458(7237):505-8
references.pmid: 19136944
references.citation: J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):362-7
references.pmid: 20412854
references.citation: Cancer Prev Res (Phila). 2011 Oct;4(10):1617-25
references.pmid: 21836023
references.citation: Cancer Prev Res (Phila). 2011 May;4(5):744-51
references.pmid: 21436386
references.citation: Carcinogenesis. 1992 Dec;13(12):2293-8
references.pmid: 1335376
references.citation: Endocrinology. 1999 May;140(5):2071-6
references.pmid: 10218956
references.citation: Breast Cancer Res. 2011 Jul 26;13(4):R74
references.pmid: 21791049
references.citation: Mol Cell Endocrinol. 2011 Dec 5;347(1-2):80-9
references.pmid: 21664236
references.citation: Cell Cycle. 2010 Jan 1;9(1):32-7
references.pmid: 20016282
references.citation: J Nutr. 2008 Sep;138(9):1658-63
references.pmid: 18716166
references.citation: Cancer Res. 2010 Mar 1;70(5):1835-44
references.pmid: 20160035
references.citation: J Invest Dermatol. 2004 Apr;122(4):984-92
references.pmid: 15102089
references.citation: J Clin Oncol. 2009 Aug 10;27(23):3757-63
references.pmid: 19451439
references.citation: Biochem Biophys Res Commun. 2008 Jul 18;372(1):30-4
references.pmid: 18485278
references.citation: J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):433-6
references.pmid: 15225815
references.citation: Clin Cancer Res. 2005 May 1;11(9):3579-86
references.pmid: 15867263
references.citation: Development. 2002 Jul;129(13):3067-76
references.pmid: 12070083
references.citation: Breast Cancer Res Treat. 1999 Mar;54(2):123-33
references.pmid: 10424403
references.citation: J Cell Physiol. 2010 Aug;224(2):433-42
references.pmid: 20432439
references.citation: Endocrinology. 1996 Feb;137(2):400-9
references.pmid: 8593782
references.citation: Mol Cell Biochem. 1998 Nov;188(1-2):13-20
references.pmid: 9823006
references.citation: Oncogene. 2009 Nov 5;28(44):3892-902
references.pmid: 19701245
references.citation: Breast Cancer Res. 2011 Aug 16;13(4):217
references.pmid: 21884640
references.citation: Biochem Pharmacol. 2006 Jul 28;72(3):332-43
references.pmid: 16737686
references.citation: J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):567-70
references.pmid: 15225840
references.citation: J Cell Biochem. 2010 Aug 15;110(6):1324-33
references.pmid: 20564226
references.citation: J Cell Biochem. 2011 Nov;112(11):3393-405
references.pmid: 21769914
references.citation: Anticancer Res. 2006 Jul-Aug;26(4A):2557-66
references.pmid: 16886664
references.citation: J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):355-61
references.pmid: 20223287
references.citation: Bone. 2010 Oct;47(4):795-803
references.pmid: 20638491
references.citation: J Surg Res. 2007 Oct;142(2):239-45
references.pmid: 17574271
references.citation: Cancer Res. 1993 Jun 1;53(11):2534-7
references.pmid: 8495416
references.citation: J Nutr. 2006 Nov;136(11):2754-9
references.pmid: 17056796
references.citation: Breast Cancer Res Treat. 2009 Jan;113(1):31-41
references.pmid: 18205042
references.citation: Breast Cancer Res Treat. 2003 Jul;80(1):49-62
references.pmid: 12889598
references.citation: Ann Surg Oncol. 2011 Jul;18(7):1830-6
references.pmid: 21573699
references.citation: J Invest Dermatol. 2011 Nov;131(11):2289-97
references.pmid: 21814234
references.citation: Therap Adv Gastroenterol. 2011 Jan;4(1):49-62
references.pmid: 21317994
references.citation: Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G208-16
references.pmid: 17962355
references.citation: J Histochem Cytochem. 2010 Mar;58(3):277-85
references.pmid: 19901270
references.citation: Prostate. 2001 Nov 1;49(3):224-33
references.pmid: 11746268
references.citation: Mol Cancer. 2011 May 18;10:58
references.pmid: 21592394
references.citation: J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):703-7
references.pmid: 17254776
references.citation: Carcinogenesis. 2002 Dec;23(12):2103-9
references.pmid: 12507934
references.citation: Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2004-13
references.pmid: 16609009
references.citation: PLoS One. 2011;6(8):e23524
references.pmid: 21858154
references.citation: BMC Genomics. 2010 Jan 13;11:26
references.pmid: 20070897
references.citation: J Steroid Biochem. 1988 Feb;29(2):265-70
references.pmid: 2831436
references.citation: PLoS Biol. 2006 Jul;4(8):e232
references.pmid: 16895439
references.citation: Nat Rev Cancer. 2007 Sep;7(9):684-700
references.pmid: 17721433
references.citation: J Exp Med. 2010 Mar 15;207(3):455-63
references.pmid: 20194632
references.citation: Recent Results Cancer Res. 2003;164:393-411
references.pmid: 12899538
references.citation: J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):368-71
references.pmid: 20347977
references.citation: J Cell Biochem. 2001;82(3):422-36
references.pmid: 11500919
references.citation: Mol Cancer Ther. 2009 Jul;8(7):1787-98
references.pmid: 19584236
references.citation: Carcinogenesis. 2010 Aug;31(8):1434-41
references.pmid: 20488884
references.citation: J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):76-9
references.pmid: 20398751
references.citation: BMC Immunol. 2007 Mar 30;8:5
references.pmid: 17397543
references.citation: Mol Cancer Ther. 2002 Jul;1(9):667-77
references.pmid: 12479363
references.citation: Cancer Res. 2002 Feb 1;62(3):741-6
references.pmid: 11830528
references.citation: Carcinogenesis. 1999 Apr;20(4):577-82
references.pmid: 10223184
references.citation: J Nutr. 2005 Oct;135(10):2350-4
references.pmid: 16177194
references.citation: Mol Cell. 2006 Mar 17;21(6):799-809
references.pmid: 16543149
references.citation: Clin Cancer Res. 2003 Jun;9(6):2350-6
references.pmid: 12796405
references.citation: Mutat Res. 2003 Feb-Mar;523-524:253-64
references.pmid: 12628523
references.citation: Mol Cell Endocrinol. 2003 Feb 28;200(1-2):67-80
references.pmid: 12644300
references.citation: Cancer Prev Res (Phila). 2011 Sep;4(9):1485-94
references.pmid: 21733837
references.citation: Cell Death Differ. 2005 Oct;12(10):1297-309
references.pmid: 15905882
references.citation: Carcinogenesis. 2001 Sep;22(9):1429-35
references.pmid: 11532865
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1653-62
references.pmid: 12496057
references.citation: Cancer Biol Ther. 2008 Oct;7(10):1570-80
references.pmid: 18769117
references.citation: J Steroid Biochem Mol Biol. 2004 Sep;92(1-2):89-95
references.pmid: 15544934
references.citation: Int J Cancer. 2012 Jan 1;130(1):10-9
references.pmid: 21328347
references.citation: Carcinogenesis. 2004 Dec;25(12):2361-72
references.pmid: 15333467
references.citation: J Invest Dermatol. 2008 Oct;128(10):2508-17
references.pmid: 18509362
references.citation: Cancer Res. 2011 Aug 1;71(15):5276-86
references.pmid: 21653679
references.citation: Mol Cell Endocrinol. 2004 Jun 30;221(1-2):67-74
references.pmid: 15223133
references.citation: Cancer Epidemiol Biomarkers Prev. 1999 Mar;8(3):241-8
references.pmid: 10090302
references.citation: Nat Genet. 2000 Jun;25(2):144-6
references.pmid: 10835626
references.citation: J Am Coll Nutr. 1999 Oct;18(5 Suppl):392S-397S
references.pmid: 10511319
references.citation: Eur J Cancer. 2000 Apr;36(6):780-6
references.pmid: 10762752
references.citation: Cancer Res. 1999 Oct 1;59(19):4848-56
references.pmid: 10519395
references.citation: Endocrinology. 1998 Apr;139(4):2102-10
references.pmid: 9528999
references.citation: Carcinogenesis. 2009 Aug;30(8):1459-68
references.pmid: 19502595
references.citation: Mol Carcinog. 2010 Apr;49(4):337-52
references.pmid: 20043299
references.citation: Cancer Chemother Pharmacol. 2001 May;47(5):429-36
references.pmid: 11391859
references.citation: Nucleic Acids Res. 2008 Jan;36(1):121-32
references.pmid: 17999998
references.citation: BMC Genomics. 2009 Oct 28;10:499
references.pmid: 19863778
references.citation: Mol Endocrinol. 2004 Sep;18(9):2208-23
references.pmid: 15178742
references.citation: Differentiation. 2007 Mar;75(3):193-207
references.pmid: 17288543
references.citation: J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):181-92
references.pmid: 12711002
references.citation: Oncologist. 2011;16(9):1215-27
references.pmid: 21835895
references.citation: Mol Endocrinol. 2003 Dec;17(12):2386-92
references.pmid: 14500760
references.citation: Prostate. 2011 Jun 15;71(9):1012-21
references.pmid: 21541977
references.citation: Recent Results Cancer Res. 2003;164:83-98
references.pmid: 12899515
references.citation: Cancer Res. 1994 Apr 1;54(7):1653-6
references.pmid: 8137276
references.citation: J Cell Biochem. 2008 Nov 1;105(4):980-8
references.pmid: 18767073
references.citation: Cancer Res. 2000 Aug 15;60(16):4412-8
references.pmid: 10969786
references.citation: Ann N Y Acad Sci. 2001 Dec;952:73-87
references.pmid: 11795445
references.citation: J Nutr. 2006 Apr;136(4):887-92
references.pmid: 16549446
references.citation: Annu Rev Pharmacol Toxicol. 2011;51:311-36
references.pmid: 20936945
references.citation: J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):763-7
references.pmid: 17257827
references.citation: J Nutrigenet Nutrigenomics. 2011;4(1):1-11
references.pmid: 21430387